Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Value of Fecal Calprotectin in Severe Alcoholic Hepatitis
NCT02808663Completed
- Sponsor
- CHU de Reims
- Start
- May 2015
- Primary completion
- Feb 2017
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by CHU de Reims. Primary endpoint: Fecal calprotectin concentration at Day 7. Started May 2015; status: completed.
Beyond the preview
Go deeper on NCT02808663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02808663.